Heavy menstrual blood loss in patients with von Willebrand disease: an unsolved problem
- PMID: 37385273
- DOI: 10.1016/S2352-3026(23)00165-5
Heavy menstrual blood loss in patients with von Willebrand disease: an unsolved problem
Conflict of interest statement
I have received unrestricted research funding from CSL Behring, Takeda, SOBI, and uniQure. I am a consultant for Biomarin, CSL Behring, Takeda, and uniQure, for which fees go to the Erasmus MC. I received personal fees for being a member of a data and safety monitoring board for Roche.
Comment on
-
Recombinant von Willebrand factor and tranexamic acid for heavy menstrual bleeding in patients with mild and moderate von Willebrand disease in the USA (VWDMin): a phase 3, open-label, randomised, crossover trial.Lancet Haematol. 2023 Aug;10(8):e612-e623. doi: 10.1016/S2352-3026(23)00119-9. Epub 2023 Jun 26. Lancet Haematol. 2023. PMID: 37385272 Free PMC article. Clinical Trial.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources